We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EBS Emergent Biosolutions Inc

-0.085 (-3.36%)
Last Updated: 14:08:16
Delayed by 15 minutes


Draw Mode:

Volume 490,499
Bid Price
Ask Price
News -
Day High 2.58


52 Week Range


Day Low 2.445
Company Name Stock Ticker Symbol Market Type
Emergent Biosolutions Inc EBS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.085 -3.36% 2.445 14:08:16
Open Price Low Price High Price Close Price Prev Close
2.52 2.445 2.58 2.53
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,003 490,499 $ 2.51 $ 1,230,404 - 1.81 - 16.6643
Last Trade Time Type Quantity Stock Price Currency
14:08:16 100 $ 2.445 USD

Emergent Biosolutions Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.67B 51.81M - 1.12B -223.8M -4.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Emergent Biosolutions News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No EBS Message Board. Create One! See More Posts on EBS Message Board See More Message Board Posts

Historical EBS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.182.6652.012.381,700,0160.26512.16%
1 Month2.122.6651.812.161,450,8010.32515.33%
3 Months4.014.291.812.801,693,486-1.57-39.03%
6 Months8.079.961.814.761,934,181-5.63-69.7%
1 Year12.1216.66431.817.351,684,091-9.68-79.83%
3 Years83.46127.201.8126.641,029,940-81.02-97.07%
5 Years69.10137.611.8138.08827,075-66.66-96.46%

Emergent Biosolutions Description

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |